Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurofibromin 1 | 4 | 2021 | 190 | 1.300 |
Why?
|
Zebrafish | 25 | 2021 | 3001 | 0.990 |
Why?
|
Neuroblastoma | 5 | 2018 | 1246 | 0.620 |
Why?
|
Thiophenes | 2 | 2021 | 569 | 0.580 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1111 | 0.500 |
Why?
|
Sulfonamides | 2 | 2021 | 1977 | 0.400 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3591 | 0.390 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2011 | 189 | 0.350 |
Why?
|
Zebrafish Proteins | 8 | 2018 | 1012 | 0.340 |
Why?
|
Pyrimidines | 2 | 2021 | 3026 | 0.340 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2012 | 664 | 0.320 |
Why?
|
Neural Stem Cells | 1 | 2016 | 886 | 0.310 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 1745 | 0.310 |
Why?
|
Embryo, Nonmammalian | 7 | 2018 | 904 | 0.310 |
Why?
|
Neoplasm Metastasis | 4 | 2017 | 4908 | 0.280 |
Why?
|
Melanoma | 3 | 2021 | 5694 | 0.270 |
Why?
|
Drug Synergism | 2 | 2021 | 1756 | 0.250 |
Why?
|
Disease Models, Animal | 9 | 2018 | 18217 | 0.240 |
Why?
|
Gene Expression | 2 | 2016 | 7567 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2016 | 2820 | 0.220 |
Why?
|
Neoplasm Transplantation | 4 | 2018 | 2010 | 0.200 |
Why?
|
Signal Transduction | 8 | 2017 | 23415 | 0.180 |
Why?
|
Neutrophils | 1 | 2012 | 3763 | 0.170 |
Why?
|
Cell Survival | 3 | 2021 | 5776 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2293 | 0.160 |
Why?
|
Cell Proliferation | 6 | 2021 | 10421 | 0.140 |
Why?
|
Embryonic Development | 3 | 2012 | 719 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2008 | 471 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 475 | 0.130 |
Why?
|
Animals, Genetically Modified | 6 | 2017 | 1559 | 0.130 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 223 | 0.130 |
Why?
|
Cell Line, Tumor | 8 | 2021 | 16947 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 987 | 0.130 |
Why?
|
Animals | 26 | 2021 | 168083 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1404 | 0.120 |
Why?
|
Cell Tracking | 1 | 2016 | 139 | 0.120 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 382 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 368 | 0.120 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1360 | 0.120 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2016 | 170 | 0.120 |
Why?
|
Sirolimus | 1 | 2021 | 1540 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8529 | 0.100 |
Why?
|
Cell Movement | 4 | 2017 | 5195 | 0.100 |
Why?
|
Beclomethasone | 1 | 2012 | 38 | 0.100 |
Why?
|
Oncogenes | 1 | 2018 | 1220 | 0.100 |
Why?
|
Dioxygenases | 1 | 2014 | 345 | 0.100 |
Why?
|
Phosphorylase Kinase | 1 | 2011 | 9 | 0.100 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2012 | 74 | 0.100 |
Why?
|
Tumor Cells, Cultured | 3 | 2018 | 6123 | 0.100 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2011 | 58 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2016 | 523 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2011 | 205 | 0.090 |
Why?
|
MAP Kinase Signaling System | 3 | 2017 | 1480 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2017 | 1720 | 0.090 |
Why?
|
Transplantation, Heterologous | 3 | 2016 | 2381 | 0.080 |
Why?
|
Repressor Proteins | 2 | 2018 | 2974 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1549 | 0.080 |
Why?
|
Transforming Growth Factor beta | 2 | 2014 | 1964 | 0.080 |
Why?
|
Carcinogens | 1 | 2011 | 452 | 0.080 |
Why?
|
Gene Amplification | 3 | 2018 | 1084 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2914 | 0.080 |
Why?
|
Gastrula | 1 | 2008 | 82 | 0.080 |
Why?
|
Myeloid Cells | 1 | 2012 | 821 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 561 | 0.070 |
Why?
|
DNA-Binding Proteins | 4 | 2017 | 9566 | 0.070 |
Why?
|
Tamoxifen | 1 | 2011 | 965 | 0.070 |
Why?
|
Pyrroles | 1 | 2012 | 1125 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2426 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2014 | 1393 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7574 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2870 | 0.060 |
Why?
|
Multigene Family | 2 | 2006 | 1075 | 0.060 |
Why?
|
Molecular Targeted Therapy | 2 | 2014 | 2813 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1830 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4933 | 0.060 |
Why?
|
Gene Expression Profiling | 4 | 2017 | 9416 | 0.050 |
Why?
|
Endothelial Cells | 2 | 2012 | 3550 | 0.050 |
Why?
|
Hyperplasia | 2 | 2017 | 1150 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 2047 | 0.050 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 2635 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 1240 | 0.050 |
Why?
|
Transcription Factors | 2 | 2018 | 12096 | 0.050 |
Why?
|
Mice | 7 | 2018 | 81324 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10203 | 0.050 |
Why?
|
Mice, Nude | 2 | 2018 | 3604 | 0.040 |
Why?
|
Humans | 18 | 2021 | 761098 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3598 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5662 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3535 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11732 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2013 | 20981 | 0.040 |
Why?
|
Response Elements | 1 | 2018 | 307 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11856 | 0.030 |
Why?
|
Neoplasms | 3 | 2016 | 22125 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2018 | 657 | 0.030 |
Why?
|
Carbazoles | 1 | 2017 | 220 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2017 | 836 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3409 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2018 | 651 | 0.030 |
Why?
|
Prostatic Neoplasms | 2 | 2014 | 11103 | 0.030 |
Why?
|
Base Sequence | 2 | 2018 | 12404 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2802 | 0.030 |
Why?
|
Rodentia | 1 | 2016 | 261 | 0.030 |
Why?
|
Transgenes | 1 | 2017 | 1008 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5870 | 0.030 |
Why?
|
Chromones | 1 | 2013 | 148 | 0.030 |
Why?
|
Dioxoles | 1 | 2013 | 95 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2013 | 144 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2014 | 194 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3696 | 0.030 |
Why?
|
Up-Regulation | 2 | 2012 | 4111 | 0.030 |
Why?
|
Melanophores | 1 | 2012 | 16 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2013 | 191 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1225 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2014 | 702 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2013 | 302 | 0.030 |
Why?
|
Luciferases | 1 | 2014 | 711 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1391 | 0.020 |
Why?
|
Dipeptides | 1 | 2013 | 387 | 0.020 |
Why?
|
Apoptosis | 2 | 2018 | 9478 | 0.020 |
Why?
|
Schwann Cells | 1 | 2012 | 196 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 714 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2915 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1900 | 0.020 |
Why?
|
Dexamethasone | 1 | 2018 | 1945 | 0.020 |
Why?
|
Stem Cells | 2 | 2014 | 3512 | 0.020 |
Why?
|
Larva | 1 | 2012 | 508 | 0.020 |
Why?
|
Morpholines | 1 | 2013 | 581 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2016 | 858 | 0.020 |
Why?
|
CpG Islands | 1 | 2014 | 1190 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13382 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3591 | 0.020 |
Why?
|
Cadherins | 1 | 2014 | 902 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 748 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2160 | 0.020 |
Why?
|
Oligodendroglia | 1 | 2012 | 538 | 0.020 |
Why?
|
Myelin Sheath | 1 | 2012 | 653 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 731 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1370 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2012 | 13404 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11066 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1496 | 0.020 |
Why?
|
Endoderm | 1 | 2008 | 160 | 0.020 |
Why?
|
Phylogeny | 2 | 2006 | 2809 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1217 | 0.020 |
Why?
|
ras Proteins | 1 | 2012 | 1054 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17598 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1331 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5033 | 0.020 |
Why?
|
Mutation | 3 | 2017 | 30006 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 931 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9300 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6198 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4250 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2014 | 2046 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10083 | 0.020 |
Why?
|
Mesoderm | 1 | 2008 | 673 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2061 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2413 | 0.010 |
Why?
|
Receptors, Interleukin-18 | 1 | 2004 | 25 | 0.010 |
Why?
|
Morphogenesis | 1 | 2008 | 741 | 0.010 |
Why?
|
Interleukin-18 Receptor alpha Subunit | 1 | 2004 | 18 | 0.010 |
Why?
|
Toll-Like Receptor 1 | 1 | 2004 | 48 | 0.010 |
Why?
|
Drug Discovery | 1 | 2012 | 1049 | 0.010 |
Why?
|
Toll-Like Receptor 5 | 1 | 2004 | 42 | 0.010 |
Why?
|
Sequence Homology | 1 | 2004 | 196 | 0.010 |
Why?
|
Toll-Like Receptor 3 | 1 | 2004 | 97 | 0.010 |
Why?
|
Toll-Like Receptor 8 | 1 | 2004 | 90 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3700 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 262 | 0.010 |
Why?
|
Learning | 1 | 2012 | 1739 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36418 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 2004 | 242 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2004 | 261 | 0.010 |
Why?
|
Toll-Like Receptor 7 | 1 | 2004 | 165 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2008 | 863 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3388 | 0.010 |
Why?
|
Motor Activity | 1 | 2012 | 2712 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 2741 | 0.010 |
Why?
|
Toll-Like Receptor 2 | 1 | 2004 | 344 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9455 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4168 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 575 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 577 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12983 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2004 | 2175 | 0.010 |
Why?
|
Kidney | 1 | 2014 | 7034 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13506 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14393 | 0.010 |
Why?
|
MicroRNAs | 1 | 2014 | 3758 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15542 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11505 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3779 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4565 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36164 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42217 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4739 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6919 | 0.010 |
Why?
|
Female | 3 | 2018 | 392458 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 64670 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74219 | 0.010 |
Why?
|
Child | 1 | 2017 | 80134 | 0.010 |
Why?
|
Male | 2 | 2014 | 360675 | 0.000 |
Why?
|